Company · CIK 1617582
Ablynx NV
| CIK | 1617582 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | C9 |
| Business address | Belgium |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2018-03-26 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-220763 | 2017-10-02 | 2017-10-25 | 8 |
Filings
10| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2017-10-25 | 424B4Final prospectus | 333-220763 | 0001193125-17-318414 |
| 2017-10-24 | EFFECTDeclared effective | 333-220763 | 9999999995-17-002772 |
| 2017-10-24 | F-1/AAmendment | 333-220763 | 0001193125-17-317497 |
| 2017-10-20 | F-1/AAmendment | 333-220763 | 0001193125-17-315472 |
| 2017-10-20 | F-1/AAmendment | 333-220763 | 0001193125-17-314728 |
| 2017-10-17 | F-1/AAmendment | 333-220763 | 0001193125-17-311335 |
| 2017-10-13 | F-1/AAmendment | 333-220763 | 0001193125-17-309113 |
| 2017-10-02 | F-1Registration filed | 333-220763 | 0001193125-17-301060 |
| 2017-06-19 | DRSDraft made public | 377-01598 | 0000950123-17-005720 |
| 2014-09-05 | EFFECTDeclared effective | 333-198467 | 9999999995-14-002690 |